Zebutinib should be used for the treatment of chronic lymphoma for as long as it is observed to be beneficial to the patient, and discontinuation should not be considered until there is progression of the disease or intolerable toxicity.
Zebutinib is used clinically for the treatment of adult sleeve cell lymphoma and adult chronic lymphocytic leukemia. When this product is used in patients with chronic gonorrhea, as long as it can be proved to be beneficial to the patient’s condition, it is necessary to keep using the drug, unless the disease has progressed or the emergence of intolerable side effects, then consider stopping the drug, so the course of medication varies from person to person.
Adverse reactions include neutropenia, thrombocytopenia, rash and leukopenia, and are contraindicated in patients who are allergic to the product.
Please follow the doctor’s instructions to adhere to the long-term use of the drug, should not stop the drug, so as not to cause the progression of the disease.